I refer to your news article above entitled “Ivermectin perlu dinilai dengan ujian klinikal sebeluem diluluskan - Dr Musa Nordin” dated 6 February 2021.
Dr Musa has questioned my call in an earlier article for the immediate approval for the use of Ivermectin as a very safe, easily available and cheap drug (in tablet form) to treat Covid-19 due to the emergency pandemic situation now, with no effective treatment yet for Covid-19.
Firstly, I wish to clarify that there are hardly any vaccine experts in our country today as we do not have a serious human vaccine development industry. The closest expert you may get is some (clinical pharmacologist & toxicologist) who studies the safety effects and efficacy of vaccines and drugs. The most important aspect of any vaccine and drug before it is to be approved for public use, is safety. The government is responsible, via the National Pharmaceutical Regulatory Agency (NPRA), to ensure the safety of all drugs and vaccines and NPRA has so far, done a good job.
In principle, as a former member of a WHO expert panel on chemical safety, I support the need to conduct the three phases of human clinical trials, in the interest of safety, for all vaccines or drugs before they are approved for public consumption. But human clinical trials can take many years and we are now in an emergency situation with many people being infected with Covid-19 and dying every day. Ivermectin could be our savior.
Ivermectin has been used for over 30 years by many millions of people with 3.7 billion doses distributed around the world with no reported severe side effects or deaths from taking it. Many recent studies around the world has shown that Ivermectin is also effective for treating Covid-19 and it has already saved many lives. Contrary to what Dr Musa said, the US National Institutes of Health has on 14 January 2021, upgraded the status of Ivermectin from “against” to “neither for or against” meaning that doctors in the US are now allowed to use Ivermectin to treat Covid-19.
Pfizer experimental vaccine was approved for use in Malaysia (without human clinical trials here) and in the US, under “Emergency Authorisation. So why can’t Ivermectin, which has been proven safe for more than 30 years, be approved under “Emergency Authorisation” as well? It can be used for prophylactic (prevention) purpose and for treating Covid patients. For prophylactic purpose, it can be immediately administered, focusing on public red zones and among the high infections areas first.
Ivermectin can also be considered as an emergency drug to be used PRIOR to the arrival of vaccines from overseas (which may be delayed) as a PLAN B. The most important consideration to make here is the safety of the medication.
If we weigh the pro and cons, I would like to appeal for Ivermectin to be approved as soon as possible for emergency use, and it should also be used under prescription by a doctor, as an additional safety measure.
Professor Dr Mustafa Ali Mohd
Clinical Pharmacologist & Toxicologist
* The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the position of Astro AWANI.
Prof Dr Mustafa Ali Mohd
Mon Feb 08 2021
'Human clinical trials can take many years and we are now in an emergency situation with many people being infected with Covid-19 and dying every day.' - Photo for illustration purpose
Astro AWANI's revamped English news website, AWANI International, launches on Oct 21
Astro AWANI's revamped English platform delivers in-depth global news and expert analysis to keep you informed on key developments.
Israeli strikes kill 33 people in Jabalia refugee camp in Gaza, medics say
Residents of Jabalia said Israeli tanks had reached the heart of the camp after pushing through suburbs and residential districts.
Liam Payne's ex-partner calls for media restraint after 'painful' death
Cheryl Tweedy used her statement to urge the media to remember they had a seven-year-old son, Bear, who could read the reports.
Analysts: Indonesia's strong MoF leadership team to boost investor confidence
Sri Mulyani Indrawati as head of Indonesia's Ministry of Finance is expected to instil confidence among investors.
Biden offers both a carrot and a stick to Israel as his term nears an end
Israel has frequently resisted US advice and has caused political difficulties for the Biden administration.
Putin says BRICS will generate most of global economic growth
Russian President Vladimir Putin will host a summit of the group in the city of Kazan on Oct. 22-24.
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.
NFOF will be operational in November 2024 with funding of RM1 bil
PM Anwar Ibrahim said NFOF will support venture capital fund managers to invest in startup companies with RM300 million set aside for 2025.
Minimum wage to increase to RM1,700 effective Feb 1, 2025
The Progressive Wage Policy would be fully enforced next year with an allocation of RM200 million, benefiting 50,000 workers.
Bursa Malaysia ends higher on Budget 2025 optimism
The benchmark index, which opened 1.85 points higher at 1,643.29, moved between 1,641.71 and 1,649.31 throughout the trading session.
Five important aspects relating to people’s lives in Budget 2025 - PM
The focus is on driving the MADANI Economy, speeding reforms, cutting red tape, raising wages, and tackling the cost of living.
Economic outlook: Govt plans to leverage, expand existing city transit system
The expansion aims to provide a more efficient and reliable public transportation network, reduce congestion, and improve accessibility.